Terms: = Breast cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Treatment
102 results:
1. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice.
Dong J; Kong L; Wang S; Xia M; Zhang Y; Wu J; Yang F; Zuo S; Wei J
J Exp Clin Cancer Res; 2024 Apr; 43(1):102. PubMed ID: 38566092
[TBL] [Abstract] [Full Text] [Related]
2. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
[TBL] [Abstract] [Full Text] [Related]
3. Stomatin-like protein-2 contributes the migration and invasion of breast cancer cells via regulating ERK/foxo3a signaling pathway.
Wu S; Zhao L; Li Q
Chin J Physiol; 2023; 66(4):257-265. PubMed ID: 37635485
[TBL] [Abstract] [Full Text] [Related]
4. Role of circ-foxo3 and miR-23a in radiosensitivity of breast cancer.
Abdollahi E; Mozdarani H; Alizadeh BZ
Breast Cancer; 2023 Sep; 30(5):714-726. PubMed ID: 37222952
[TBL] [Abstract] [Full Text] [Related]
5. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma.
Lee YM; Chen YH; Ou DL; Hsu CL; Liu JH; Ko JY; Hu MC; Tan CT
J Pathol; 2023 Apr; 259(4):428-440. PubMed ID: 36641765
[TBL] [Abstract] [Full Text] [Related]
6. Identifying Patients Whose Symptoms Are Underrecognized During treatment With breast Radiotherapy.
Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
[TBL] [Abstract] [Full Text] [Related]
7. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in breast cancer Cells by Regulating the MAPKs and AKT/foxo3a Signaling Pathways.
Ock CW; Kim GD
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771123
[TBL] [Abstract] [Full Text] [Related]
8. The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs.
Cansaran-Duman D; Yangın S; Çolak B
Biol Res; 2021 Nov; 54(1):37. PubMed ID: 34743742
[TBL] [Abstract] [Full Text] [Related]
9. AKT inhibitor AZD5363 suppresses stemness and promotes anti-cancer activity of 3,3'-diindolylmethane in human breast cancer cells.
Zhu K; Liu X; Liu C; Xu Y; Fu Y; Dong W; Yan Y; Wang W; Qian C
Toxicol Appl Pharmacol; 2021 Oct; 429():115700. PubMed ID: 34464674
[TBL] [Abstract] [Full Text] [Related]
10. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract] [Full Text] [Related]
11. Disruption of foxo3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer.
Luo L; Zhang Z; Qiu N; Ling L; Jia X; Song Y; Li H; Li J; Lyu H; Liu H; He Z; Liu B; Zheng G
Nat Commun; 2021 May; 12(1):2699. PubMed ID: 33976188
[TBL] [Abstract] [Full Text] [Related]
12. Effects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer.
Ozates NP; Soğutlu F; Lerminoglu F; Demir B; Gunduz C; Shademan B; Avci CB
Life Sci; 2021 Jan; 264():118643. PubMed ID: 33141044
[TBL] [Abstract] [Full Text] [Related]
13. Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-foxo3 axis to modulate cancer drug resistance and clonal survival.
Alasiri G; Jiramongkol Y; Trakansuebkul S; Ke HL; Mahmud Z; Intuyod K; Lam EW
Mol Cell Endocrinol; 2020 Sep; 515():110932. PubMed ID: 32615282
[TBL] [Abstract] [Full Text] [Related]
14. Cytosolic and mitochondrial ROS production resulted in apoptosis induction in breast cancer cells treated with Crocin: The role of foxo3a, PTEN and AKT signaling.
Nasimian A; Farzaneh P; Tamanoi F; Bathaie SZ
Biochem Pharmacol; 2020 Jul; 177():113999. PubMed ID: 32353423
[TBL] [Abstract] [Full Text] [Related]
15. An Overview of the Potential Antineoplastic Effects of Casticin.
Ramchandani S; Naz I; Lee JH; Khan MR; Ahn KS
Molecules; 2020 Mar; 25(6):. PubMed ID: 32178324
[TBL] [Abstract] [Full Text] [Related]
16. Inflammatory macrophage derived TNFα downregulates estrogen receptor α via foxo3a inactivation in human breast cancer cells.
Gunnarsdóttir FB; Hagerling C; Bergenfelz C; Mehmeti M; Källberg E; Allaoui R; Mohlin S; Påhlman S; Larsson C; Jirström K; Bexell D; Leandersson K
Exp Cell Res; 2020 May; 390(1):111932. PubMed ID: 32145253
[TBL] [Abstract] [Full Text] [Related]
17. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/foxo3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract] [Full Text] [Related]
18. Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) treatment of Patients with ER
Robertson JFR; Coleman RE; Cheung KL; Evans A; Holcombe C; Skene A; Rea D; Ahmed S; Jahan A; Horgan K; Rauchhaus P; Littleford R; Cheung SYA; Cullberg M; de Bruin EC; Koulai L; Lindemann JPO; Pass M; Rugman P; Schiavon G; Deb R; Finlay P; Foxley A; Gee JMW
Clin Cancer Res; 2020 Apr; 26(7):1574-1585. PubMed ID: 31836609
[TBL] [Abstract] [Full Text] [Related]
19. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated foxo3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract] [Full Text] [Related]
20. The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Cairns J; Ingle JN; Kalari KR; Shepherd LE; Kubo M; Goetz MP; Weinshilboum RM; Wang L
Breast Cancer Res; 2019 Apr; 21(1):47. PubMed ID: 30944027
[TBL] [Abstract] [Full Text] [Related]
[Next]
